Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$47.98 - $54.4 $590,585 - $669,609
-12,309 Reduced 68.23%
5,732 $310,000
Q4 2023

Feb 14, 2024

SELL
$48.48 - $57.85 $155,136 - $185,120
-3,200 Reduced 15.07%
18,041 $925,000
Q3 2023

Nov 14, 2023

SELL
$57.89 - $64.73 $11,578 - $12,946
-200 Reduced 0.93%
21,241 $1.23 Million
Q2 2023

Aug 07, 2023

SELL
$63.71 - $70.74 $22,298 - $24,759
-350 Reduced 1.61%
21,441 $1.37 Million
Q1 2023

May 03, 2023

SELL
$65.71 - $74.53 $25,955 - $29,439
-395 Reduced 1.78%
21,791 $1.51 Million
Q1 2022

May 02, 2022

SELL
$61.48 - $73.72 $61,480 - $73,720
-1,000 Reduced 4.31%
22,186 $1.62 Million
Q4 2021

Feb 10, 2022

SELL
$53.63 - $62.52 $296,466 - $345,610
-5,528 Reduced 19.25%
23,186 $1.45 Million
Q2 2021

Jul 30, 2021

SELL
$61.91 - $67.42 $12,382 - $13,484
-200 Reduced 0.69%
28,714 $1.92 Million
Q1 2021

May 13, 2021

BUY
$59.34 - $66.74 $71,208 - $80,088
1,200 Added 4.33%
28,914 $1.83 Million
Q4 2020

Feb 12, 2021

SELL
$57.74 - $65.43 $184,768 - $209,376
-3,200 Reduced 10.35%
27,714 $1.72 Million
Q3 2020

Nov 06, 2020

SELL
$57.43 - $63.64 $45,944 - $50,912
-800 Reduced 2.52%
30,914 $1.86 Million
Q1 2020

May 14, 2020

SELL
$46.4 - $67.43 $27,468 - $39,918
-592 Reduced 1.83%
31,714 $1.77 Million
Q4 2019

Feb 10, 2020

BUY
$49.21 - $64.19 $192,312 - $250,854
3,908 Added 13.76%
32,306 $2.07 Million
Q3 2019

Nov 12, 2019

SELL
$42.77 - $50.71 $128,310 - $152,130
-3,000 Reduced 9.55%
28,398 $1.44 Million
Q2 2019

Aug 07, 2019

SELL
$44.62 - $49.34 $40,827 - $45,146
-915 Reduced 2.83%
31,398 $1.42 Million
Q1 2019

May 13, 2019

SELL
$45.12 - $53.8 $53,737 - $64,075
-1,191 Reduced 3.55%
32,313 $1.54 Million
Q4 2018

Feb 13, 2019

SELL
$48.76 - $63.23 $3.72 Million - $4.82 Million
-76,238 Reduced 69.47%
33,504 $1.74 Million
Q3 2018

Nov 08, 2018

SELL
$55.19 - $62.25 $274,680 - $309,818
-4,977 Reduced 4.34%
109,742 $6.81 Million
Q2 2018

Aug 06, 2018

SELL
$50.53 - $62.98 $554,111 - $690,638
-10,966 Reduced 8.72%
114,719 $6.35 Million
Q1 2018

May 04, 2018

BUY
$59.92 - $68.98 $22,649 - $26,074
378 Added 0.3%
125,685 $7.95 Million
Q4 2017

Feb 01, 2018

SELL
$59.94 - $65.35 $282,077 - $307,537
-4,706 Reduced 3.62%
125,307 $7.68 Million
Q3 2017

Nov 08, 2017

BUY
$55.23 - $63.74 $7.18 Million - $8.29 Million
130,013
130,013 $8.29 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Granite Investment Partners, LLC Portfolio

Follow Granite Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Granite Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Granite Investment Partners, LLC with notifications on news.